Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial
Journal article
Taylor WR. et al, (2023), The Lancet Infectious Diseases, 23, 471 - 483
Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial
Journal article
Tripura R. et al, (2023), The Lancet Infectious Diseases, 23, 81 - 90
Investigating secondary use of clinical research data: a protocol for a mixed methods study (Preprint)
Journal article
Waithira N. et al, (2022), JMIR Research Protocols
Correction: Assessing the impact of a novel house design on the incidence of malaria in children in rural Africa: study protocol for a household-cluster randomized controlled superiority trial.
Journal article
Mshamu S. et al, (2022), Trials, 23
Assessing the impact of a novel house design on the incidence of malaria in children in rural Africa: study protocol for a household-cluster randomized controlled superiority trial.
Journal article
Mshamu S. et al, (2022), Trials, 23
Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
Journal article
Peto TJ. et al, (2022), The Lancet Infectious Diseases, 22, 867 - 878
Community seroprevalence and risk factors for SARS-CoV-2 infection in different subpopulations in Vellore, India, and their implications for future prevention.
Journal article
Dayanand D. et al, (2022), International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 116, 138 - 146
Comparison of statistical methods for the analysis of recurrent adverse events in the presence of non-proportional hazards and unobserved heterogeneity: a simulation study.
Journal article
Patson N. et al, (2022), BMC medical research methodology, 22
Contribution of genetic factors to high rates of neonatal hyperbilirubinaemia on the Thailand-Myanmar border.
Journal article
Bancone G. et al, (2022), PLOS Glob Public Health, 2
Effect of adverse events on non-adherence and study non-completion in malaria chemoprevention during pregnancy trial: A nested case control study.
Journal article
Patson N. et al, (2022), PloS one, 17
Effect of patient-delivered household contact tracing and prevention for tuberculosis: A household cluster-randomised trial in Malawi.
Journal article
Kaswaswa K. et al, (2022), PloS one, 17
Under the Mask: A Film on Tuberculosis at the Thai-Myanmar Border.
Journal article
Delmas MV. et al, (2022), Frontiers in public health, 10
Clustering of malaria in households in the Greater Mekong Subregion: operational implications for reactive case detection
Journal article
Mukaka M. et al, (2021), Malaria Journal, 20
Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
Journal article
Taylor WR. et al, (2021), Malaria Journal, 20
Evolution of Multidrug Resistance in Plasmodium falciparum: a Longitudinal Study of Genetic Resistance Markers in the Greater Mekong Subregion
Journal article
Imwong M. et al, (2021), Antimicrobial Agents and Chemotherapy, 65
Addressing the statistical analysis dilemma that exists when analyzing clinical trial results with full efficacy using the Kaplan Meier survival analysis method
Journal article
Peerawaranun P. et al, (2021), Experimental Results, 2
Joint modelling of multivariate longitudinal clinical laboratory safety outcomes, concomitant medication and clinical adverse events: application to artemisinin-based treatment during pregnancy clinical trial.
Journal article
Patson N. et al, (2021), BMC medical research methodology, 21
High levels of pathological jaundice in the first 24 hours and neonatal hyperbilirubinaemia in an epidemiological cohort study on the Thailand-Myanmar border
Journal article
Thielemans L. et al, (2021), PLOS ONE, 16, e0258127 - e0258127
Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.
Journal article
Hamaluba M. et al, (2021), The Lancet. Infectious diseases, 21, 1395 - 1406